The DEA’s Cannabis Rescheduling Hearing: A Setback for Reform in 2024
The Drug Enforcement Administration (DEA) has introduced yet another delay in its consideration of rescheduling cannabis, pushing any substantive movement into 2025. This development has sparked disappointment among advocates, patients, and industry stakeholders who...
Cannabis in 2024: A Turning Point for Federal Policy
The cannabis industry is at a pivotal moment as the U.S. approaches a significant decision: rescheduling cannabis under federal law. This could reshape everything from research accessibility to market dynamics and legal implications. What’s Happening? The DEA’s...
Cannabis Dispensaries: More Than Just Retail
Today’s cannabis dispensaries are a far cry from the simple storefronts of the past. They’ve evolved into dynamic spaces that focus on education, wellness, and creating a welcoming experience for everyone—from curious first-timers to seasoned cannabis enthusiasts....